Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Response to: 'is there a direct relationship between serum level of methotrexate and clinical efficacy and tolerability?' by Fleishman and Yazici.

Schiff MH, Jaffe JS, Freundlich B.

Ann Rheum Dis. 2014 Sep;73(9):e55. doi: 10.1136/annrheumdis-2014-205938. Epub 2014 Jun 24. No abstract available.

PMID:
24962874
2.

Is there a direct relationship between serum level of methotrexate and clinical efficacy and tolerability?

Fleischmann R, Yazici Y.

Ann Rheum Dis. 2014 Sep;73(9):e54. doi: 10.1136/annrheumdis-2014-205901. Epub 2014 Jun 3. No abstract available.

PMID:
24894190
3.

Benefit and risk of methotrexate treatment in rheumatoid arthritis.

Rau R, Herborn G.

Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S83-94. Review.

PMID:
15552520
4.

Parenteral methotrexate for the treatment of rheumatoid arthritis.

Yazici Y, Bata Y.

Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:46-8. Review.

5.
6.

Tofacitinib versus methotrexate in rheumatoid arthritis.

Yuan K, Chen J, Xu A.

N Engl J Med. 2014 Sep 18;371(12):1163-4. doi: 10.1056/NEJMc1408607#SA2. No abstract available.

PMID:
25229928
7.

Tofacitinib versus methotrexate in rheumatoid arthritis.

Sexton D.

N Engl J Med. 2014 Sep 18;371(12):1163. doi: 10.1056/NEJMc1408607#SA1. No abstract available.

PMID:
25229927
8.

Tofacitinib versus methotrexate in rheumatoid arthritis.

Wilkinson B, Krishnaswami S, van Vollenhoven RF.

N Engl J Med. 2014 Sep 18;371(12):1164-5. doi: 10.1056/NEJMc1408607. No abstract available.

9.

Cyclosporine and methotrexate for severe rheumatoid arthritis.

Malleson P.

N Engl J Med. 1995 Dec 7;333(23):1567; author reply 1568-9. No abstract available.

PMID:
7477177
10.

Optimal use of methotrexate: the advantages of tight control.

Bijlsma JW, Weinblatt ME.

Ann Rheum Dis. 2007 Nov;66(11):1409-10.

11.

[Subcutaneous self-administration of methotrexate in rheumatoid arthritis].

Huisman AM, Schouten JP, van Paassen HC, Wouters JM, Jacobs JW.

Ned Tijdschr Geneeskd. 1996 Jul 27;140(30):1564-5. Dutch. No abstract available.

PMID:
8765767
12.

[Methotrexate and folates in rheumatoid arthritis].

Endresen GK, Husby G.

Tidsskr Nor Laegeforen. 1999 Feb 10;119(4):534-7. Review. Norwegian.

PMID:
10081378
13.

Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.

Ornetti P, Solau E, Gaudin P, Sibilia J, Berthelot JM, Puechal X, Tavernier C, Maillefert JF; Club Rhumatismes et Inflammation from the French Society of Rheumatology.

Ann Rheum Dis. 2005 Sep;64(9):1379-80. No abstract available.

14.

Safe prescribing of methotrexate for rheumatoid arthritis.

Kirkham BW.

Med J Aust. 1995 Sep 4;163(5):278. No abstract available.

PMID:
7565224
15.

Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis.

Wassenberg S, Rau R.

J Rheumatol. 2003 Aug;30(8):1891; author reply 1891-2. No abstract available.

16.

Combination of sulphasalazine and methotrexate in the treatment of rheumatoid arthritis.

Dougados M.

Z Rheumatol. 1998 Feb;57(1):31-3. Review. No abstract available.

PMID:
9566104
17.

Subcutaneous methotrexate is well tolerated and superior to oral methotrexate in the treatment of rheumatoid arthritis.

Hameed B, Jones H.

Int J Rheum Dis. 2010 Oct;13(4):e83-4. doi: 10.1111/j.1756-185X.2010.01482.x. No abstract available.

PMID:
21199461
18.

Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.

Parker CT, Mewshaw E, Dennis GJ.

J Am Osteopath Assoc. 2004 Jan;104(1):7-8. No abstract available.

PMID:
14992316
19.

Therapy: oral or subcutaneous methotrexate for rheumatoid arthritis?

Alsaeedi S, Keystone EC.

Nat Rev Rheumatol. 2014 Oct;10(10):578-9. doi: 10.1038/nrrheum.2014.129. Epub 2014 Aug 5. No abstract available.

PMID:
25090946
20.

Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis.

Protogerou AD, Zampeli E, Sfikakis PP.

Ann Intern Med. 2012 Aug 21;157(4):299-300; author reply 300. doi: 10.7326/0003-4819-157-4-201208210-00019. No abstract available.

PMID:
22910947
Items per page

Supplemental Content

Write to the Help Desk